Stocks and Investing
Stocks and Investing
Thu, November 30, 2017
[ 12:00 AM ] - United States, WOPRAI
Wed, November 29, 2017
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Tue, November 28, 2017
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Mon, November 27, 2017
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Edward Tenthoff Upgraded (ARWR) to Buy on, Nov 27th, 2017
Edward Tenthoff of Piper Sandler, Upgraded "Arrowhead Pharmaceuticals, Inc." (ARWR) to Buy on, Nov 27th, 2017.
Edward has made no other calls on ARWR in the last 4 months.
There is 1 other peer that has a rating on ARWR. Out of the 1 peers that are also analyzing ARWR, 0 agree with Edward's Rating of Hold.
This is the rating of the analyst that currently disagrees with Edward
- Y Katherine Xu of "William Blair" Upgraded from Hold to Buy on, Monday, September 18th, 2017
Contributing Sources